The world’s most expensive drug can’t cure what disease This biotechnology

Bluebird Bio is about to become the seller of the two most expensive drugs in the United States, and globally, each bringing in nearly $3 million a year.

While the high price tag has led to a public backlash, one would think that the company and its investors would at least see a huge profit like the drug. finally hit the market. Not necessarily. Two Food and Drug Administration approvals this past summer may have rescued the company from the financial abyss, but Boston-area-based Bluebird in April announced cost cuts substantial costs to maintain operations, will be short of money for a while.


News7F: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button